Comments of Jeffery B. Keane, Chief Executive Officer, Noble Biomaterials, Inc. on May. 07, 2022

Subject: “File No. SR-NYSEArca-2021-90”
From: Jeffery B. Keane, Chief Executive Officer, Noble Biomaterials, Inc.
Affiliation:

May. 07, 2022

I support this converstion. It makes sense for the investor and regulator.

Jeff Keane


Jeffery Keane 
Chief Executive Officer 
Noble Biomaterials, Inc.

Subject: “File No. SR-NYSEArca-2021-90” From: Jeffery B. Keane, Chief Executive Officer, Noble Biomaterials, Inc. Affiliation:

Subject: “File No. SR-NYSEArca-2021-90”
From: Jeffery B. Keane, Chief Executive Officer, Noble Biomaterials, Inc.
Affiliation: